| ID | CAS | Name | Synonyms | Description |
|---|---|---|---|---|
| 1 | 1000413-72-8 | [(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy]-3-biphenylyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid | CS-54 TAK875 TAK875 TAK-875 TAK 875. TAK-875,TAK875 TAK-875(Fasiglifam) (3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid [(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy]-3-biphenylyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid 3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)- 3-Benzofuranacetic acid, 6-[[2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-, (3S)- | Inhibitors;Organic materials;Hydrocarbon compounds |
| 2 | 168828-81-7 | N-benzyloxycarbonyl-3-fluoro-4-morpholinoaniline | Linezolid Intermediate 1 Linezolid Benzyl IMpurity Intermediate of Linezolid 3 N-CARBOBENZOXY-3-FLUORO-4-MORPHOLINYL-ANILINE Benzyl (3-fluoro-4-Morpholinophenyl)carbaMate N-BENZYLOXYCARBONYL-3-FLUORO-4-MORPHOLINOANILINE N-benzyloxycarbonyl-3-fluoro-4-morpholinoaniline benzyl (3-fluoro-4-morpholin-4-ylphenyl)carbamate Benzyl 3-Fluoro-4-(4-Morpholinyl)phenyl)carbaMate (3-Fluoro-4-morpholin-4-ylphenyl)carbamic acid benzyl ester N-[3-fluoro-4-(4-morpholinyl)phenyl]carbamic acid (phenylmethyl) ester CarbaMic acid, N-[3-fluoro-4-(4-Morpholinyl)phenyl]-, phenylMethyl ester | Intermediates;Pharmaceutical intermediates |
| 3 | 461432-26-8 | (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | Daglican BMS-512148 Dapagliflozi BMS-512148-05 Dapagliflozin DAPAGLIFLOZIN DAPAGLIFLOZIN BASE Dapagliflozin propanediol Dapagliflozin S1548 Selleck (1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | I;API;APIs;Aromatics;Heterocycles;Organic intermediates;Pharmaceutical raw materials;G protein coupled receptors & G proteins;Small molecule inhibitors, natural products;Pharmaceutical raw materials-s |
| 4 | 62284-79-1 | (-)-4-BROMOTETRAMISOLE OXALATE | R 30402 L-P-BROMOTETRAMISOLE OXALATE (-)-P-BROMOLEVAMISOLE OXALATE (-)-4-BROMOTETRAMISOLE OXALATE (-)-P-BROMOTETRAMISOLE OXALATE L-(-)-P-BROMOTETRAMISOLE OXALATE (-)-P-BROMOTETRAMISOLE OXALATE SALT (-)-p-Bromolevamisole oxalate Ready Made Solution (-)-p-Bromotetramisole oxalate【(S)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate】 | chiral;Inhibitors |
| 5 | 515814-01-4 | Voclosporin | Lx211 R 1524 Luveniq Isatx 247 Voclosporin Voclosporin [usan] | Peptides;Pharmaceuticals;Intermediates & Fine Chemicals |
| 6 | 1303420-67-8 | PLX5622 | PLX5622 PLX 5622 PLX-5622 5-Fluoro-N-[6-fluoro-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-2-methoxy-3-pyridinemethanamine 6-FLUORO-N-((5-FLUORO-2-METHOXYPYRIDIN-3-YL)METHYL)-5-((5-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)METHYL)PYRIDIN-2-AMINE 3-Pyridinemethanamine, 5-fluoro-N-[6-fluoro-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-2-methoxy- | API |
| 7 | 2152628-33-4 | LOXO-292 | LOX-292 CPD2206 LOXO-292 SELPERCATINIB LOXO-292,Selpercatinib | GS;API |
| 8 | 1038915-60-4 | Niraparib | Niraparib MK4827 (Niraparib) Niraparib (MK-4827) 2-[4-((3S)-3-Piperidinyl)phenyl]-2H-indazole-7-carboxamide (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide 2H-Indazole-7-carboxamide, 2-[4-(3S)-3-piperidinylphenyl]- MK-4827,(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide | Intermediates-Pharmaceutical Intermediates |
| 9 | 1029044-16-3 | Pexidartinib | PLX-3397 Pexidartinib 5-((5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl) N-[5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine 3-Pyridinemethanamine,N-[5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)- | |
| 10 | 878672-00-5 | RDEA 594 | RDEA 594 Lesinurad Lesinurad (RDEA-594) Lesinurad impurity1-12 Lesinurad (with 3 ints.) 2-[[5-BroMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid 2-{[5-broMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid | Lesinurad (RDEA-594) |
| 11 | 1628260-79-6 | 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile;ziritaxestat | GLPG-1690 5-Thiazolecarbonitrile, 2-[[2-ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)- 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile ziritaxestat | Intermediates-Pharmaceutical Intermediates |
| 12 | 1442472-39-0 | Ripretinib | DCC-2618 DCC2618 DCC 2618 Ripretinib RIPRETINIB Ripretinib (DCC-2618) N-[4-Bromo-5-[1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-N'-phenylurea | API;Intermediates-Pharmaceutical Intermediates |
| 13 | 2097002-61-2 | LOXO-195 | CS-2800 LOXO195 LOXO-195 Selitrectinib LOXO 195(Selitrectinib) selitrectinib(LOXO-195) (3aR,10R)-5-Fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-12H-15,17-ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one 12H-15,17-Ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one, 5-fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-, (3aR,10R)- | Intermediates-Pharmaceutical Intermediates |
| 14 | 1609392-27-9 | BMS-986165 | Tyk2-IN-4 BMS-986165 Deucravacitinib Deucravacitinib (TYK2-IN-4 Deucravacitinib(BMS986165) 6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H?)methylpyridazine-3-carboxamide 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl) phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide | API;APIS |
| 15 | 67526-95-8 | Thapsigargin | Thapsigargin (3S,3aR,4S,6S,6AR,7S,8S,9bS)-6-(Acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl octanoate Octanoic acid, (3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-buten-1-yl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]f uran-7-yl ester | Antibiotics;Biochemical reagents |
| 16 | 464-74-4 | Arenobufagin | Arenobufagin arenobufagin Arenobufogenin Arenobufagin, BR 3β,11α,14-Trihydroxy-12-oxo-5β-bufa-20,22-dienolide Bufa-20,22-dienolide,3,11,14-trihydroxy-12-oxo-, (3b,5b,11a)- Bufa-20,22-dienolide, 3,11,14-trihydroxy-12-oxo-, (3β,5β,11α)- (3beta,5beta,11alpha)-3,11,14-Trihydroxy-12-oxobufa-20,22-dienolide (3beta,5beta,8xi,9xi,11alpha)-3,11,14-trihydroxy-12-oxobufa-20,22-dienolide | Plant extract;Standard substance;Reference substance;Standard substance-tradi;Traditional Chinese medicine reference substance;Reference substance-traditional Chinese medicine reference substance |
| 17 | 844694-85-5 | Donepezil Benzyl Bromide (Donepezil Impurity) | Donepezil-004-Br Donepezil Impurity Donepezil Benzyl BroMide Donepezil Benzyl Bromide (Donepezil Impurity) 1-Benzyl-4-(5,6-dimethoxy-1H-2-indenylmethyl)piperidine 4-[(5,6-Dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine 4-[(2,3-Dihydro-5,6-diMethoxy-1-oxo-1H-inden-2-yl)Methyl]-1,1-bis(phenylMethyl) 4-[(2,3-Dihydro-5,6-dimethoxy-1-oxo-1H-inden-2-yl)methyl]-1,1-bis(phenylmethyl) Piperidinium Bromide | Aromatics;Impurities;Heterocycles;Pharmaceuticals;Aromatics Compounds;Chemical impurity-donepezil;Intermediates & Fine Chemicals |
| 18 | 28097-03-2 | Chaetocin from Chaetomium minutum | chetocin Chaetocin Chaetocin A CHAETOCIN(SH) HMTase Inhibitor II, Chaetocin CHAETOCIN FROM CHAETOMIUM MINUTUM Chaetocin from Chaetomium minutum | Standards;Antibiotics;Cell biology;Miscellaneous Enzyme;Microbial metabolites;Chemical raw materials |
| 19 | 22061-78-5 | 2-bromo-3-methyl-phenol | 164881 2-bromo-3-methyl-phenol 2-Bromo-3-hydroxytoluene Phenol, 2-broMo-3-Methyl- | Halides;Phenyls & Phenyl-Het;Aromatic hydrocarbons;Phenyls & Phenyl-Het;Pharmaceutical intermediates |
| 20 | 852821-06-8 | (4aS,8aS,9S)-3-(Benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2 | TP808 TP 808 CS-1875 (4aS,8aS,9S)-3-(Benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2 (4aS,8aS,9S)-3-(Benzyloxy)-4a-((tert-butyldiMethylsilyl)oxy)-9-(diMethylaMino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH,8H)-dione (4aS,8aS,9S)-3-(benzyloxy)-4a-(tert-butyldimethylsilyloxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH,8H)-dione TP808 (4aS,8aS,9S)-9-(Dimethylamino)-4a-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-8a,9-dihydro-3-(phenylmethoxy)-naphth[2,3-d]isoxazole-4,5(4aH,8H)-dione Naphth[2,3-d]isoxazole-4,5(4aH,8H)-dione, 9-(dimethylamino)-4a-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-8a,9-dihydro-3-(phenylmethoxy)-, (4aS,8aS,9S)- (4aS,8aS,9S)-9-(Dimethylamino)-4a-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-8a,9-dihydro-3-(phenylmethoxy)-naphth[2,3-d]isoxazole-4,5(4aH,8H)-dione TP-808 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 21 | 139504-50-0 | Mertansine | DM 1 Mertansine MERTANSINE 139504-50-0 DM1 Compound DM1 COMPOUND Maytansine DM1 DM1 Mertansine UNII-DDZ29HGH0E UNII-DDZ29HGH0E Maytansinoid dM 1 MAYTANSINOID DM 1 N2'-deacetyl-N2'-(3-Mercapto-1-oxopropyl)-Maytansine Maytansine, N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)- | R;Inhibitors;Medical raw materials;Antibody Drug Conjugates;Small molecule inhibitors;Pharmaceutical bulk drugs;API [for scientific research only];Series of scientific research raw drugs;Small molecul |
| 22 | 743420-02-2 | Chidamide | CHIDAMIDE Chidamide Chidamide,HBI-8000, CS-055 De-4-fluoro 5-Fluoro Chidamide (E)-N-(2-AMINO-5-FLUOROPHENYL)-4-((3-(PYRIDIN-3-YL)ACRYLAMIDO)METHYL)BENZAMIDE (E)-N-(2-aMino-5-fluorophenyl)-4-((3-(pyridin-3-yl)acrylaMido)Methyl)benzaMide N-(2-Amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propenyl]amino]methyl]benzamide (E)-N-(2-amino-5-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide Chidamide | Cell biology reagent |
| 23 | 254750-02-2 | Emricasan | (S)-3-((S)-2-(2-(2-tert-butylphenylaMino)-2-oxoacetaMido)propana (3S)-3-[(N-{[(2-tert-butylphenyl)amino](oxo)acetyl}-L-alanyl)amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid (S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid N-[2-(tert-butyl)phenyl]-2-oxoglycyl-N-[(1S)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]-L-alaninamide | Chemical reagent |
| 24 | 6823-69-4 | 4',4''-Di-2-imidazolin-2-yl-p-benzenediacrylanilide dihydrochloride | GW4869 CS-2410 GW69A, GW554869A N-SMase Inhibitor GW4869 dihydrochloride GW 4869 (hydrochloride hydrate) 4',4''-Di-2-imidazolin-2-yl-p-benzenediacrylanilide dihydrochloride | API;Inhibitor;A cell-permeable, symmetrical dihydroimidazolo-amide compound that acts as a potent, specific, non-competitive inhibitor of N-SMase. |
| 25 | 1080028-80-3 | Zamicastat | BIA 5-1058 2H-Imidazole-2-thione, 1-[(3R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]- | Bioactive molecule-API |
| 26 | 2252403-56-6 | AMG-510 racemate | AMG510 AMG 510 AMG-510 CPD2809 AMG-510 racemate chiral AMG 510, single isomer 6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-1-[4-METHYL-2-(PROPAN-2-YL)PYRIDIN-3-YL]-4-[(2S)-2-METHYL-4-(P 4-((S)-4-acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]-1H,2H-pyrido[2,3-d]pyrimidin-2-one | GS;API;Anti-virus;Inhibitors;Shaanxi Linnae;Chemical industry;Export raw materials;Additive intermediates;Scientific research export;Pharmaceutical raw materials |
| 27 | 203640-27-1 | (R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid | S 3304 R-3-(1H-Indol-3-yl)-2-(5-(p-tolyleth ynyl)thiophene-2 D-Tryptophan, N-[[5-[2-(4-methylphenyl)ethynyl]-2-thienyl]sulfonyl]- (R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid (R)-3-(1H-Indol-3-yl)-2-(5-p-tolylethynyl-thiophene-2-sulfonylamino)-propionic acid (2R)-3-(1H-indol-3-yl)-2-{5-[2-(4-methylphenyl)ethynyl]thiophene-2-sulfonamido}propanoic acid (2R)-3-(1H-indol-3-yl)-2-[[5-[2-(4-methylphenyl)ethynyl]thiophen-2-yl]sulfonylamino]propanoic acid | |
| 28 | 161796-84-5 | Esomeprazole potassium | Esomeprazole potassium (S)-Omeprazole potassium (S)-5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d] potassium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide (R)-5-METHOXY-2-((4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHYLSULFINYL)BENZO[D]IMIDAZOL-1-IDE POTASSIUM SALT | API;Medical raw materials;Pharmaceutical bulk drugs |
| 29 | 1629654-95-0 | PD-1/PD-L1 Inhibitor 3 | Glycinamide, N-(2-mercaptoacetyl)-L-phenylalanyl-N-methyl-L-alanyl-L-asparaginyl-L-prolyl-L-histidyl-L-leucyl-N-methylglycyl-L-tryptophyl-L-seryl-L-tryptophyl-N-methyl-L-norleucyl-N-methyl-L-norleucyl-L-arginyl-L-cysteinyl-, cyclic (1→14)-thioether | Polypeptide inhibitor |
| 30 | 915942-22-2 | Neratinib Maleate | Nerlynx Neratinib Maleate Neratinib Maleate fandachem (E)-N-[4-[3-Chloro-4-[(2-pyridinyl)methoxy]anilino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide maleate (E)-N-{4-[3-chloro-4-(pyridin-2-yl methoxy) anilino]-3-cyano-7-ethoxyquinolin-6-yl}-4- (dimethylamino)but-2-enamide maleate | API;Anti-tumor;Organic chemistry;Medical raw materials;Pharmaceutical raw materials |
| 31 | 1350636-82-6 | WSMXIQXWHPSVDE-WHAUHWDVSA-N | BC-3781 ACETATE Lefamulin acetate WSMXIQXWHPSVDE-WHAUHWDVSA-N | Inhibitor |
| 32 | 1578245-44-9 | BOS-172722 | BOS-172722 N2-(2-ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine Pyrido[3,4-d]pyrimidine-2,8-diamine, N8-(2,2-dimethylpropyl)-N2-[2-ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl]-6-methyl- | Standard |
| 33 | 117796-52-8 | Sch 37370 | Sch 37370 N-Acetyldesloratadine N-Acetyldesloratadine N N-acetyl base loratadine 1-(4-(8-chloro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(6H)-ylidene)piperidin-1-yl)ethanone 1-Acetyl-4-[(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin)-11-ylidene]piperidine 1-[4-(8-chloro-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-11-ylidene)piperidin-1-yl]ethanone 1-[4-[(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)-11-ylidene]piperidino]ethanone | Impurity controls;Aromatics, heterotypes, Metabolites & medicines, Pharmaceuticals, mediates & Fine Chemicals;Aromatics, Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine |